Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -137.27%-58.3M | ---- | 146.95%156.43M | ---- | -9,795.84%-333.19M | ---- | ---3.37M | ---- | 221.73%32.62M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -55.75%-975K | ---- | 47.53%-626K | ---- | -65.24%-1.19M | ---- | ---722K | ---- | -153.80%-769K | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | -79.56%46K | ---- | --225K | ---- | 2,404.17%601K | ---- |
| Impairment and provisions: | 63.48%5.71M | ---- | -98.97%3.49M | ---- | 12,737.38%338.05M | ---- | ---2.68M | ---- | -82.17%377K | ---- |
| -Impairment of trade receivables (reversal) | 1,768.71%5.71M | ---- | -100.84%-342K | ---- | 1,618.92%40.63M | ---- | ---2.68M | ---- | -82.17%377K | ---- |
| -Other impairments and provisions | ---- | ---- | -98.71%3.83M | ---- | --297.42M | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | --19K | ---- | 9,458.23%7.55M | ---- |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | --19K | ---- | 9,458.23%7.55M | ---- |
| Asset sale loss (gain): | --4.97M | ---- | ---- | ---- | -91.22%56K | ---- | --638K | ---- | 43.89%318K | ---- |
| -Loss (gain) from sale of subsidiary company | --4.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | --424K | ---- | ---- | ---- | -91.22%56K | ---- | --638K | ---- | 43.89%318K | ---- |
| Depreciation and amortization: | 26.12%7.1M | ---- | 10.04%5.63M | ---- | -45.35%5.12M | ---- | --9.37M | ---- | 45.04%5.47M | ---- |
| -Depreciation | ---- | ---- | ---- | ---- | -34.50%4.79M | ---- | --7.32M | ---- | 8.36%3.68M | ---- |
| Financial expense | 47.27%5.29M | ---- | -42.65%3.59M | ---- | -65.04%6.26M | ---- | --17.92M | ---- | 418.01%14.44M | ---- |
| Special items | 116.38%27.54M | ---- | ---168.08M | ---- | ---- | ---- | --73K | ---- | ---- | ---- |
| Operating profit before the change of operating capital | -2,042.15%-8.66M | ---- | -97.06%446K | ---- | -29.45%15.15M | ---- | --21.47M | ---- | 221.85%60.61M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -139.07%-4.92M | ---- | 2,043.27%12.58M | ---- | 109.94%587K | ---- | ---5.91M | ---- | 62.54%-5M | ---- |
| Accounts receivable (increase)decrease | 165.96%30.31M | ---- | 49.59%-45.96M | ---- | -608.91%-91.17M | ---- | --17.92M | ---- | 0.30%-94.27M | ---- |
| Accounts payable increase (decrease) | -232.28%-64.09M | ---- | 43.98%48.45M | ---- | 101.54%33.65M | ---- | --16.7M | ---- | -112.01%-2.81M | ---- |
| Cash from business operations | -405.06%-47.36M | ---- | 137.15%15.52M | ---- | -183.28%-41.79M | ---- | --50.18M | ---- | 36.86%-41.47M | ---- |
| Other taxs | -941.49%-8.26M | ---- | 75.13%-793K | ---- | 19.79%-3.19M | ---- | ---3.98M | ---- | -308.77%-3.12M | ---- |
| Special items of business | ---- | -85.81%-54.91M | ---- | 12.83%-29.55M | ---- | 19.59%-33.9M | ---- | 11.30%-42.17M | ---- | 44.42%-47.54M |
| Net cash from operations | -477.56%-55.61M | -85.81%-54.91M | 132.75%14.73M | 12.83%-29.55M | -197.35%-44.97M | 19.59%-33.9M | --46.2M | 11.30%-42.17M | 30.53%-44.59M | 44.42%-47.54M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 55.75%975K | -67.45%474K | -47.53%626K | 265.83%1.46M | 65.24%1.19M | 18.10%398K | --722K | 89.33%337K | 153.80%769K | 44.72%178K |
| Sale of fixed assets | -99.87%2K | ---- | 58.76%1.49M | -8.24%936K | 163.66%936K | 10,100.00%1.02M | --355K | -91.80%10K | 88.43%228K | 19.61%122K |
| Purchase of fixed assets | 52.78%-13.31M | 92.97%-1.47M | -81.59%-28.18M | -306.47%-20.92M | -12.31%-15.52M | 16.63%-5.15M | ---13.82M | -79.22%-6.17M | -203.36%-19.13M | -48.68%-3.45M |
| Sale of subsidiaries | ---14K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---500K | ---- |
| Other items in the investment business | ---- | ---- | ---10K | ---- | ---- | ---- | ---- | ---- | ---- | ---500K |
| Net cash from investment operations | 52.67%-12.35M | 94.62%-997K | -94.77%-26.08M | -396.89%-18.53M | -5.09%-13.39M | 36.00%-3.73M | ---12.74M | -59.86%-5.83M | 18.72%-18.63M | -74.24%-3.65M |
| Net cash before financing | -498.70%-67.96M | -16.28%-55.91M | 80.55%-11.35M | -27.77%-48.08M | -274.44%-58.37M | 21.58%-37.63M | --33.46M | 6.23%-47.99M | 27.43%-63.22M | 41.58%-51.18M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 59.58%159.58M | -40.02%45M | 33.33%100M | 114.37%75.03M | 882.06%75M | 0.00%35M | --7.64M | --35M | ---- | ---- |
| Refund | -33.33%-100M | ---- | -882.06%-75M | -358.30%-35M | 80.91%-7.64M | ---7.64M | ---40M | ---- | 6.22%-38.14M | ---- |
| Interest paid - financing | -47.27%-5.29M | -27.70%-2.6M | -76.68%-3.59M | 28.56%-2.04M | 54.93%-2.03M | -72.31%-2.85M | ---4.51M | -65.23%-1.65M | -18.15%-2.06M | -37.50%-1M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---1.86M | ---- | ---610K | ---- |
| Absorb investment income | ---- | 50.00%300K | --200K | --200K | ---- | ---- | ---- | ---- | --360K | ---- |
| Net cash from financing operations | 154.85%53.97M | 11.82%42.44M | -67.53%21.18M | 54.84%37.96M | 260.54%65.21M | -24.67%24.51M | ---40.62M | 1,806.40%32.54M | -175.88%-42.17M | -110.25%-1.91M |
| Effect of rate | 509.47%8.11M | 323.40%3.01M | -79.02%1.33M | -123.85%-1.35M | 127.29%6.34M | 271.60%5.64M | --2.79M | -402.58%-3.29M | -205.03%-3.46M | 165.17%1.09M |
| Net Cash | -242.37%-13.99M | -32.99%-13.47M | 43.49%9.83M | 22.80%-10.13M | 195.60%6.85M | 15.09%-13.12M | ---7.16M | 70.90%-15.45M | -234.09%-105.38M | 23.07%-53.09M |
| Begining period cash | 24.06%57.53M | 24.07%57.55M | 39.68%46.38M | 39.72%46.39M | -11.64%33.2M | -11.64%33.2M | --37.58M | -74.34%37.58M | -16.17%146.42M | -16.17%146.42M |
| Cash at the end | -10.23%51.65M | 34.88%47.09M | 24.02%57.53M | 35.72%34.91M | 39.72%46.39M | 36.58%25.73M | --33.2M | -80.05%18.84M | -74.34%37.58M | -9.20%94.42M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.